Skip to Main Content

Author Details

Man-Seong Park
Korea University College of Medicine
2001
118
24
PMIDPaper TitleJournal TitlePublished Year
36669564Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: A prospective cohort study.J Infect2023
37702580A natural variation in the RNA polymerase of severe fever with thrombocytopenia syndrome virus enhances viral replication and in vivo virulence.J Med Virol2023
37680469Molecular evolution and targeted recombination of SARS-CoV-2 in South Korea.iScience2023
37563335Stabilization of RNA G-quadruplexes in the SARS-CoV-2 genome inhibits viral infection via translational suppression.Arch Pharm Res2023
37244782Corrigendum to "Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection" [J Infect 85 (2022) e69-e71].J Infect2023
36973368Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2.Sci Rep2023
37003909Comparison of culture-competent virus shedding duration of SARS-CoV-2 Omicron variant in regard to vaccination status: A prospective cohort study.Vaccine2023
36960070Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection.Front Immunol2023
36856164In vitro and in vivo suppression of SARS-CoV-2 replication by a modified, short, cell-penetrating peptide targeting the C-terminal domain of the viral spike protein.J Med Virol2023
36634813Establishment of multicenter COVID-19 therapeutics preclinical test system in Republic of Korea.Pulm Pharmacol Ther2023
36458559Comparison of secondary attack rate and viable virus shedding between patients with SARS-CoV-2 Delta and Omicron variants: A prospective cohort study.J Med Virol2023
34400343Diagnostic usefulness of subgenomic RNA detection of viable SARS-CoV-2 in patients with COVID-19.Clin Microbiol Infect2022
35842468Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants.Sci Rep2022
35351541Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment.J Infect2022
35839776Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition.Cell Rep2022
35705135Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection.J Infect2022
35608859Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.JAMA Netw Open2022
35765097Laboratory information management system for COVID-19 non-clinical efficacy trial data.Lab Anim Res2022
35502502Nosocomial Outbreak by Delta Variant From a Fully Vaccinated Patient.J Korean Med Sci2022
36680068Production of a Monoclonal Antibody to the Nucleocapsid Protein of SARS-CoV-2 and Its Application to ELISA-Based Detection Methods with Broad Specificity by Combined Use of Detector Antibodies.Viruses2022
36215268Comparison of vaccination efficacy using live or ultraviolet-inactivated influenza viruses introduced by different routes in a mouse model.PLoS One2022
36341265Daily, self-test rapid antigen test to assess SARS-CoV-2 viability in de-isolation of patients with COVID-19.Front Med (Lausanne)2022
35931794Kinetics of neutralizing antibodies against SARS-CoV-2 infection according to sex, age, and disease severity.Sci Rep2022
36298836Serological Evidence of Severe Fever with Thrombocytopenia Syndrome Virus and IgM Positivity Were Identified in Healthy Residents in Vietnam.Viruses2022
36125147Clinical Application of a Solid-Phase Assay for SARS-CoV-2 IgG to Predict a Neutralizing Antibody Titer.Clin Lab2022
36324270Temporal Transcriptome Analysis of SARS-CoV-2-Infected Lung and Spleen in Human ACE2-Transgenic Mice.Mol Cells2022
36223658Clinical scoring system to predict viable viral shedding in patients with COVID-19.J Clin Virol2022
36192424Author Correction: Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants.Sci Rep2022
36222118Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models.Dis Model Mech2022
35881005The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2.Science2022
36217571Evaluation of In-Hospital Cluster of COVID-19 Associated With a Patient With Prolonged Viral Shedding Using Whole-Genome Sequencing.J Korean Med Sci2022
33685546Feasibility of ultraviolet light-emitting diode irradiation robot for terminal decontamination of coronavirus disease 2019 (COVID-19) patient rooms.Infect Control Hosp Epidemiol2022
35235179Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines.J Microbiol2022
35023551COVID-19 Cluster Linked to Aerosol Transmission of SARS-CoV-2 via Floor Drains.J Infect Dis2022
33436577A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein.Nat Commun2021
33875625Multifactorial Traits of SARS-CoV-2 Cell Entry Related to Diverse Host Proteases and Proteins.Biomol Ther (Seoul)2021
33731494Antiviral Efficacy of Pralatrexate against SARS-CoV-2.Biomol Ther (Seoul)2021
33617577Human infection with Seoul orthohantavirus in Korea, 2019.PLoS Negl Trop Dis2021
33783327TRIM28 functions as a negative regulator of aggresome formation.Autophagy2021
33503337Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19.N Engl J Med2021
33664866MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein.Theranostics2021
33808752Specific Detection of Influenza A and B Viruses by CRISPR-Cas12a-Based Assay.Biosensors (Basel)2021
34943430Performance Evaluation of the BZ COVID-19 Neutralizing Antibody Test for the Culture-Free and Rapid Detection of SARS-CoV-2 Neutralizing Antibodies.Diagnostics (Basel)2021
34868052MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants.Front Immunol2021
34433827A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome.Nat Commun2021
34407077Seroepidemiologic survey of emerging vector-borne infections in South Korean forest/field workers.PLoS Negl Trop Dis2021
34427062Frequent Occurrence of SARS-CoV-2 Transmission among Non-close Contacts Exposed to COVID-19 Patients.J Korean Med Sci2021
34834940Dynamics of Viral Shedding and Symptoms in Patients with Asymptomatic or Mild COVID-19.Viruses2021
34216126Nosocomial Outbreak of COVID-19 in a Hematologic Ward.Infect Chemother2021
34099809Effective inactivated influenza vaccine for the elderly using a single-stranded RNA-based adjuvant.Sci Rep2021
  • 1 - 50 of 118

Recommended Authors

Icahn School of Medicine at Mount Sinai New York
Career Start Year 2015
Number of shared co-authors 8
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 2011
Number of shared co-authors 9
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 10
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2010
Number of shared co-authors 4
Stanford University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 10
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 0
Biodesign Center for Fundamental and Applied Microbiomics, Arizona State University
Career Start Year 2007
Number of shared co-authors 2
FluGen Inc.
Career Start Year 2007
Number of shared co-authors 0
Influenza Research Institute, University of Wisconsin
Career Start Year 2006
Number of shared co-authors 2
NYU Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 5
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 5
Harbin Veterinary Research Institute
Career Start Year 2005
Number of shared co-authors 0
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 0
College of Life Sciences, Inner Mongolia University
Career Start Year 2005
Number of shared co-authors 5
Institute of Medical Virology, University of Zurich
Career Start Year 2004
Number of shared co-authors 7
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 3
School of Clinical Medicine, The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 0
University of Iowa
Career Start Year 2002
Number of shared co-authors 8
Icahn School of Medicine at Mount Sinai
Career Start Year 2001
Number of shared co-authors 14
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 2000
Number of shared co-authors 2
University of California riverside
Career Start Year 1999
Number of shared co-authors 8
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 1993
Number of shared co-authors 3
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 2
Center for Vaccines and Immunology, University of Georgia
Career Start Year 1991
Number of shared co-authors 2
Centers for Disease Control and Prevention.
Career Start Year 1989
Number of shared co-authors 6
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 6
University of North Carolina
Career Start Year 1981
Number of shared co-authors 4
Influenza Research Institute, University of Wisconsin
Career Start Year 1979
Number of shared co-authors 5

Collaborators

Icahn School of Medicine at Mount Sinai
Co-authored papers 11
Korea Food Research Institute
Co-authored papers 8
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Rega Institute, Laboratory of Clinical and Evolutionary Virology
Co-authored papers 4
Seoul National University
Co-authored papers 4
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Sydney Institute for Infectious Diseases, The University of Sydney
Co-authored papers 1
Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia
Co-authored papers 1
Institute for Viral Diseases, College of Medicine, Korea University
Co-authored papers 1
David Geffen School of Medicine, University of California los angeles
Co-authored papers 1
University of California
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Bonita Vista High School, University of California San Diego, University of California, San Diego
Co-authored papers 1
Co-authored papers 1
University of California
Co-authored papers 1
The Scripps Research Institute
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Merck & Co., Inc.
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Co-authored papers 1
Malaysia Genome and Vaccine Institute, National Institute of Biotechnology Malaysia
Co-authored papers 1
Malaysia Genome and Vaccine Institute
Co-authored papers 1
Tulane University School of Medicine
Co-authored papers 1
University of California
Co-authored papers 1
University of Arizona
Co-authored papers 1
University of California
Co-authored papers 1
University of California San Diego
Co-authored papers 1
the Scripps Research Institute
Co-authored papers 1
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1